Physician
Regional Medical Oncology Center PA
Regional Medical Oncology Center PA was paid $860K by Medicaid between Jan 2018 and Dec 2024, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoREGIONAL MEDICAL ONCOLOGY CENTER PA
WILSON, NC 27893
WILSON, NC 27893
33aNPI1407117948assigned 05/31/2012
33bProvider typeHematology & Oncology Physician
28Total paid$860K
24GClaims45,174
24DCodes billed23
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in North Carolina
Rank by total paid#2 of 46
Median peer was paid$36K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,167 | $87K | |
| 2019 | 6,657 | $126K | |
| 2020 | 5,082 | $94K | |
| 2021 | 5,374 | $131K | |
| 2022 | 6,861 | $216K | |
| 2023 | 7,552 | $114K | |
| 2024incomplete | 6,481 | $92K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 7,951 | 6,529 | $291K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 16% | 75 | 57 | $137K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 9.9% | 1,556 | 727 | $85K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.1% | 15,863 | 10,372 | $61K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 5.8% | 525 | 276 | $50K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.7% | 665 | 473 | $41K |
| 99205 | Prolong outpt/office vis | 4.4% | 362 | 331 | $38K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.5% | 4,478 | 2,632 | $30K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.5% | 1,317 | 868 | $30K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.0% | 1,111 | 276 | $26K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 2.6% | 60 | 39 | $22K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.0% | 803 | 694 | $17K |
11 more codes
| 96367 | 1.9% | 867 | $16K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 419 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,297 | $5K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 45 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 426 | $2K |
| 99223 | Prolong inpt eval add15 m | <1% | 36 | $793.72 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 944 | $270.82 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,219 | $180.78 |
| 96415 | <1% | 20 | $114.72 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 114 | $34.23 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 21 | $4.95 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLERRO, KEITH (OWNER)